Evidence map›Paper›PMID 36765922›Full record

ArticleCancers2023

MR Intensity Normalization Methods Impact Sequence Specific Radiomics Prognostic Model Performance in Primary and Recurrent High-Grade Glioma.

Patrick Salome, Francesco Sforazzini, Gianluca Grugnara, Andreas Kudak, Matthias Dostal, Christel Herold-Mende, Sabine Heiland, Jürgen Debus, Amir Abdollahi, Maximilian Knoll

Abstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. RN-DFrontiers in artificial intelligence · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Patrick SalomeClinical Cooperation Unit (CCU) Radiation Oncology, German Cancer Research Centre, INF 280, 69120 Heidelberg, Germany.ORCID 0000-0003-4978-9156
Francesco SforazziniClinical Cooperation Unit (CCU) Radiation Oncology, German Cancer Research Centre, INF 280, 69120 Heidelberg, Germany.
Gianluca GrugnaraDepartment of Neuroradiology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Andreas KudakHeidelberg Ion-Beam Therapy Centre (HIT), INF 450, 69120 Heidelberg, Germany.ORCID 0000-0002-1474-1403
Matthias DostalHeidelberg Ion-Beam Therapy Centre (HIT), INF 450, 69120 Heidelberg, Germany.ORCID 0000-0003-1873-235X
Christel Herold-MendeBrain Tumour Group, European Organization for Research and Treatment of Cancer, 1200 Brussels, Belgium.ORCID 0000-0002-1915-745X
Sabine HeilandDepartment of Neuroradiology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Jürgen DebusGerman Cancer Consortium (DKTK) Core Centre Heidelberg, 69120 Heidelberg, Germany.
Amir AbdollahiClinical Cooperation Unit (CCU) Radiation Oncology, German Cancer Research Centre, INF 280, 69120 Heidelberg, Germany.ORCID 0000-0002-8016-5897
Maximilian KnollClinical Cooperation Unit (CCU) Radiation Oncology, German Cancer Research Centre, INF 280, 69120 Heidelberg, Germany.ORCID 0000-0002-9037-3980

Funding

H2020 MSCA-ITN PREDICT 766276
6 · The paper itself

Abstract

purposeThis study investigates the impact of different intensity normalization (IN) methods on the overall survival (OS) radiomics models' performance of MR sequences in primary (pHGG) and recurrent high-grade glioma (rHGG).

methodsMR scans acquired before radiotherapy were retrieved from two independent cohorts (rHGG C1: 197, pHGG C2: 141) from multiple scanners (15, 14). The sequences are T1 weighted (w), contrast-enhanced T1w (T1wce), T2w, and T2w-FLAIR. Sequence-specific significant features (SF) associated with OS, extracted from the tumour volume, were derived after applying 15 different IN methods. Survival analyses were conducted using Cox proportional hazard (CPH) and Poisson regression (POI) models. A ranking score was assigned based on the 10-fold cross-validated (CV) concordance index (C-I), mean square error (MSE), and the Akaike information criterion (AICs), to evaluate the methods' performance.

resultsScatter plots of the 10-CV C-I and MSE against the AIC showed an impact on the survival predictions between the IN methods and MR sequences (C1/C2 C-I range: 0.62-0.71/0.61-0.72, MSE range: 0.20-0.42/0.13-0.22). White stripe showed stable results for T1wce (C1/C2 C-I: 0.71/0.65, MSE: 0.21/0.14). Combat (0.68/0.62, 0.22/0.15) and histogram matching (HM, 0.67/0.64, 0.22/0.15) showed consistent prediction results for T2w models. They were also the top-performing methods for T1w in C2 (Combat: 0.67, 0.13; HM: 0.67, 0.13); however, only HM achieved high predictions in C1 (0.66, 0.22). After eliminating IN impacted SF using Spearman's rank-order correlation coefficient, a mean decrease in the C-I and MSE of 0.05 and 0.03 was observed in all four sequences.

conclusionThe IN method impacted the predictive power of survival models; thus, performance is sequence-dependent.

Indexed as

high-grade gliomaimage preprocessingintensity harmonizationintensity standardizationmultiparametric MRIradiomics signatures

Identifiers

PMID36765922
PMCPMC9913466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.